Media Summary: Roy H Behnke MD Grand Rounds William Scott Burgin MD. Mira Katan, MD, MSc, FESO, University Hospital and University of Basel, Basel, Switzerland, talks on the use of 7th Munich Metabolomics Symposium 14.11.2020 Dr. Steffen Tiedt LMU Munich List of Speakers and titles in this playlist (Day 2): ...

Molecular Biomarkers Of Ischemic Stroke - Detailed Analysis & Overview

Roy H Behnke MD Grand Rounds William Scott Burgin MD. Mira Katan, MD, MSc, FESO, University Hospital and University of Basel, Basel, Switzerland, talks on the use of 7th Munich Metabolomics Symposium 14.11.2020 Dr. Steffen Tiedt LMU Munich List of Speakers and titles in this playlist (Day 2): ... Ana Catarina Fonseca, MD, PhD, University of Lisbon, Lisbon, Portugal, discusses recent updates on Mira Katan, MD, MSc, FESO, University Hospital and University of Basel, Basel, Switzerland, discusses various What are ischemic strokes? Ischemic strokes occur when there's a blocked artery that reduces blood flow to the brain. Find ...

John McCabe, MB, BCh, BAO, MRCPI, PhD, Mater Misericordiae University Hospital, Dublin, Ireland, comments on the limitations ... Mira Katan, MD, MSc, FESO, University Hospital of Zurich, Zurich, Switzerland, discusses the use of Please note: This presentation is delivered in French. This webinar offers a practical approach to acute-phase brain MRI in ... Maria Alonso De Leciñana, MD, PhD, La Paz University Hospital, Madrid, Spain, comments on the potential of blood-based ... Thrombogenicity can be categorized into cardiac, vascular, or systemic origin. Magnus Bäck, MD, PhD, Karolinska Institutet, ... Ke Jian (Jim) Liu, Ph.D., Professor, Pharmaceutical Sciences at the University of New Mexico describes his technology "Blood ...

Neurofilament light chain (NfL) has been identified as a sensitive but non-specific blood-based Video abstract of a review paper "Advances in the diagnosis of exosomal miRNAs in Louis Caplan, MD, Harvard Medical School, Boston, MA, talks about how Marios K. Georgakis, MD, PhD, Mass General Hospital, Harvard Medical School, Boston, MA & LMU Munich University Hospital, ... Speaker: Jason D. Hinman, PhD, MD Physician-Scientist/Associate Professor/Vice Chair of Research Department of Neurology, ...

Photo Gallery

Molecular Biomarkers of Ischemic Stroke
Using biomarkers to guide secondary prevention in ischemic stroke
Circulating metabolites differentiate acute ischemic stroke from stroke mimics
Biomarkers in thrombotic and embolic stroke
Blood biomarkers for stroke diagnosis and secondary prevention
Ischemic Stroke - causes, symptoms, diagnosis, treatment, pathology
Ischemia Care and Applied Biosystems microarrays in stroke research and biomarker signatures
The limitations of studies investigating inflammatory biomarkers after ischemic stroke or TIA
Blood biomarkers to guide secondary stroke prevention with anticoagulation
Webinar Replay (FR): MRI Biomarkers in Ischemic Stroke: From Signal to Treatment
The potential of blood-based biomarkers to differentiate ischemic and hemorrhagic stroke
Developing blood-based biomarkers for stroke
Sponsored
Sponsored
View Detailed Profile
Molecular Biomarkers of Ischemic Stroke

Molecular Biomarkers of Ischemic Stroke

Roy H Behnke MD Grand Rounds William Scott Burgin MD.

Using biomarkers to guide secondary prevention in ischemic stroke

Using biomarkers to guide secondary prevention in ischemic stroke

Mira Katan, MD, MSc, FESO, University Hospital and University of Basel, Basel, Switzerland, talks on the use of

Sponsored
Circulating metabolites differentiate acute ischemic stroke from stroke mimics

Circulating metabolites differentiate acute ischemic stroke from stroke mimics

7th Munich Metabolomics Symposium 14.11.2020 Dr. Steffen Tiedt LMU Munich List of Speakers and titles in this playlist (Day 2): ...

Biomarkers in thrombotic and embolic stroke

Biomarkers in thrombotic and embolic stroke

Ana Catarina Fonseca, MD, PhD, University of Lisbon, Lisbon, Portugal, discusses recent updates on

Blood biomarkers for stroke diagnosis and secondary prevention

Blood biomarkers for stroke diagnosis and secondary prevention

Mira Katan, MD, MSc, FESO, University Hospital and University of Basel, Basel, Switzerland, discusses various

Sponsored
Ischemic Stroke - causes, symptoms, diagnosis, treatment, pathology

Ischemic Stroke - causes, symptoms, diagnosis, treatment, pathology

What are ischemic strokes? Ischemic strokes occur when there's a blocked artery that reduces blood flow to the brain. Find ...

Ischemia Care and Applied Biosystems microarrays in stroke research and biomarker signatures

Ischemia Care and Applied Biosystems microarrays in stroke research and biomarker signatures

Interview Jeff June,

The limitations of studies investigating inflammatory biomarkers after ischemic stroke or TIA

The limitations of studies investigating inflammatory biomarkers after ischemic stroke or TIA

John McCabe, MB, BCh, BAO, MRCPI, PhD, Mater Misericordiae University Hospital, Dublin, Ireland, comments on the limitations ...

Blood biomarkers to guide secondary stroke prevention with anticoagulation

Blood biomarkers to guide secondary stroke prevention with anticoagulation

Mira Katan, MD, MSc, FESO, University Hospital of Zurich, Zurich, Switzerland, discusses the use of

Webinar Replay (FR): MRI Biomarkers in Ischemic Stroke: From Signal to Treatment

Webinar Replay (FR): MRI Biomarkers in Ischemic Stroke: From Signal to Treatment

Please note: This presentation is delivered in French. This webinar offers a practical approach to acute-phase brain MRI in ...

The potential of blood-based biomarkers to differentiate ischemic and hemorrhagic stroke

The potential of blood-based biomarkers to differentiate ischemic and hemorrhagic stroke

Maria Alonso De Leciñana, MD, PhD, La Paz University Hospital, Madrid, Spain, comments on the potential of blood-based ...

Developing blood-based biomarkers for stroke

Developing blood-based biomarkers for stroke

Steffen Tiedt, PhD, Institute for

Biomarkers of cardiac thrombogenicity to distinguish cardioembolic and atherothrombotic stroke risk

Biomarkers of cardiac thrombogenicity to distinguish cardioembolic and atherothrombotic stroke risk

Thrombogenicity can be categorized into cardiac, vascular, or systemic origin. Magnus Bäck, MD, PhD, Karolinska Institutet, ...

Blood Biomarker for Early Blood Brain Barrier Disruption in Ischemic Stroke

Blood Biomarker for Early Blood Brain Barrier Disruption in Ischemic Stroke

Ke Jian (Jim) Liu, Ph.D., Professor, Pharmaceutical Sciences at the University of New Mexico describes his technology "Blood ...

The potential of NfL as a biomarker for stroke

The potential of NfL as a biomarker for stroke

Neurofilament light chain (NfL) has been identified as a sensitive but non-specific blood-based

Exosomal miRNAs as ischemic stroke biomarkers - Video abstract [ID 216784]

Exosomal miRNAs as ischemic stroke biomarkers - Video abstract [ID 216784]

Video abstract of a review paper "Advances in the diagnosis of exosomal miRNAs in

Challenges with biomarkers in stroke

Challenges with biomarkers in stroke

Louis Caplan, MD, Harvard Medical School, Boston, MA, talks about how

One-third of Ischemic Strokes are of Unknown Cause.

One-third of Ischemic Strokes are of Unknown Cause.

Ischemic Stroke

Targeting IL-6 signaling in ischemic stroke

Targeting IL-6 signaling in ischemic stroke

Marios K. Georgakis, MD, PhD, Mass General Hospital, Harvard Medical School, Boston, MA & LMU Munich University Hospital, ...

A Novel Blood-Based Biomarker for Silent Cerebral Edema and Brain Vascular Injury

A Novel Blood-Based Biomarker for Silent Cerebral Edema and Brain Vascular Injury

Speaker: Jason D. Hinman, PhD, MD Physician-Scientist/Associate Professor/Vice Chair of Research Department of Neurology, ...